Begue et al. [79] found that PON1 is less abundant in HDL molecules isolated from patients who suffered from COVID-19, and HDLs themselves possess some quantitative and qualitative abnormalities, such as enrichment in acute phase proteins and decreased Apo-A1 levels. Here, PON1 is linked to COVID-19.